RARA CRAFT DATABASE for FDA Medical Devices
510(k)K212306

FDA DEVICE FACTS

Tapestry Biointegrative Implant

Embody, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 2, 2021PRODUCT CODEOWY

Indications for use

TAPESTRY is indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue. TAPESTRY® Biointegrative Implant Embody, Inc. Traditional Premarket 510(k) Notification K212306 SUBSTANTIAL EQUIVALENCE SUMMARY TAPESTRY is the same device as its TAPESTRY predicate, with the same indications for use, design, materials, and technological charact eristics and, therefore is substantially equivalent . Validation methods for establishing collagen stability throughout TAPESTRY’s shelf life has been added to support expansion of the shelf life of the subject device . Two new product size/shape offerings, within the originally cleared size range, have been added based on user feedback.

SUMMARY OF PERFORMANCE TESTING TAPESTRY is the same device as its predicate, TAPESTRY (K201572), in regard to all aspects of the device. Only the collagen stabil ity validation method changed between the current device and the predicate device. Past performance testing (safety, biocompatibility, bench) of the predicate device is directly applicable to the subject device. Additional tests to confirm the collagen stability of the device were performed. Hydroxyproline analysis was conducted to confirm the collagen quantity and Fourier Transform Infrared (FTIR) analysis was conducted to confirm collagen quality. Together with the product stability testing of the predicate device, the collagen stability testing will be used to support expansion of the shelf life of the subject device. No new performance testing was required to support the additional product sizes, as the sizes a re within the cleared size range and the cleared labeling allows for trimming of the device. The performance testing demonstrates that TAPESTRY is substantially equivalent to the predicate device.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026